Cancer Antigen 125 (CA 125)

CA 125 (synonym: cancer antigen 125) is a so-called tumor marker. Tumor markers are substances produced naturally in the body by tumors and are detectable in the blood. They can provide an indication of a malignant (malignant) neoplasm and serve as a follow-up examination in the context of cancer aftercare.

The procedure

Material needed

  • Blood serum

Preparation of the patient

  • Not necessary

Disruptive factors

  • None known

Standard values

Normal value < 33 U/ml (> 65 U/ml clearly pathological)
Women up to 50 years of age <38 U/ml
Women > 50 years of age <31 U/ml

Indications

  • Patients with suspected ovarian or pancreatic tumors (ovarian and pancreatic tumors).
  • Follow-up and therapy control in the above tumors.

Interpretation

Interpretation of increased values

  • Ovarian cancer (ovarian cancer; the positive predictive value of indicating invasive ovarian cancer is approximately 40%; the specificity (probability that actually healthy individuals who do not have the disease in question will also be identified as healthy by the test) is 99.9%)
  • Pancreatic cancer (pancreatic cancer; detectable in up to 80% of cases).
  • Cholangiocarcinoma (bile duct carcinoma)
  • Colon carcinoma (colon cancer; detectable in up to 20-40% of cases).
  • Gastric carcinoma (stomach cancer; detectable in up to 40% of cases).
  • Mammary carcinoma (breast cancer; detectable in up to 10% of cases).
  • Cervical carcinoma (cervical cancer; detectable in up to 10% of cases).
  • Acute pancreatitis (inflammation of the pancreas; up to 500 U/ml).
  • Autoimmune diseases such as collagenoses
  • Endometriosis – occurrence of endometrium (uterine lining) extrauterine (outside the uterine cavity).
  • Hepatitis (inflammation of the liver)
  • Liver cirrhosis – connective tissue remodeling of the liver, which leads to functional limitations.
  • Peritonitis (inflammation of the peritoneum)
  • Pregnancy (up to 200 U/ml)

Interpretation of lowered values

  • No diagnostic significance

Further notes

  • Ovarian cancer screening using CA 19-9 with fixed thresholds is not possible! On the one hand, elevated values cannot reliably indicate the disease, and on the other hand, low values cannot reliably exclude a tumor. In one study, it was shown that the rate of change of CA-105 20 concentration can improve the risk calculation.
  • When pancreatic cancer (pancreatic cancer) is suspected, CA 19-9 should always be determined as well.